Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART621 Dose Optimisation in Rheumatoid Arthritis
NCT00854685Phase 2Completed
- Sponsor
- Arana Therapeutics
- Start
- Feb 2009
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of placulumab in rheumatoid arthritis (RA), sponsored by Arana Therapeutics. Started Feb 2009; status: completed.
02
Drugs
placulumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00854685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854685.